Niemann–Pick disease type C

Niemann–Pick disease, type C
Other namesNiemann–Pick disease, type D
NPC1, the protein that is mutated in Niemann–Pick disease, type C
SpecialtyEndocrinology, neurology Edit this on Wikidata
SymptomsHepatosplenomegaly, dementia
ComplicationsAkinetic mutism, respiratory arrest
Usual onset50% by the age of 10
DurationLonger duration if symptoms begin later in life, most die by the age of 13
TypesType C1, type C2, type D (obsolete)
CausesMutations in the NPC1 and NPC2 genes
Risk factorsHaving parents with the disease, or parents that are carriers of the disease
Diagnostic methodGene sequencing
Differential diagnosisOther childhood dementias
PreventionGene editing
TreatmentArimoclomol, levacetylleucine, experimental treatments, and palliative care
MedicationArimoclomol and levacetylleucine
PrognosisInvariably fatal, duration varies
Frequency1 in 150,000

Niemann–Pick type C (NPC) (colloquially, "Childhood Alzheimer's") is a lysosomal storage disease associated with mutations in NPC1 and NPC2 genes. Niemann–Pick type C affects an estimated 1:150,000 people. Approximately 50% of cases present before ten years of age, but manifestations may first be recognized as late as the sixth decade. Despite its name, Niemann-Pick disease, type C has very little to do with SMPD1-associated Niemann–Pick disease, although they were once thought to be the same disease.